Trials / Completed
CompletedNCT03251261
Detection of Cytomegalovirus Virus in Neonates
Illumigene CMV Clinical Trial Protocol
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,615 (actual)
- Sponsor
- Meridian Bioscience, Inc. · Industry
- Sex
- All
- Age
- 20 Days
- Healthy volunteers
- Accepted
Summary
To evaluate the illumigene CMV assay, using the illumipro-10 with neonates (up to 21 days of age) saliva swabs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | illumigene CMV assay, illumipro-10 | CMV assay for detection of CMV |
Timeline
- Start date
- 2017-08-02
- Primary completion
- 2018-03-05
- Completion
- 2018-03-05
- First posted
- 2017-08-16
- Last updated
- 2019-01-14
Locations
5 sites across 4 countries: United States, Australia, Canada, Italy
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03251261. Inclusion in this directory is not an endorsement.